SCOPUS 정보 검색 플랫폼

Australian Journal of Chemistry

Volumn 65, Issue 1, 2012, Pages 5-14

Cancer targeted nanoparticles specifically induce apoptosis in cancer cells and spare normal cells

(4) Kanwar, Jagat R a Kanwar, Rupinder K a Mahidhara, Ganesh a Cheung, Chun Hei Antonio b

a DEAKIN UNIVERSITY (Australia)

b NATIONAL CHENG KUNG UNIVERSITY (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE EFFECT; APTAMERS; CANCER CELLS; CHEMOTHERAPEUTIC AGENTS; CHEMOTHERAPEUTIC DRUGS; DNA NUCLEOTIDES; EPITHELIAL CELL ADHESION MOLECULES; IN-VITRO; LOCKED NUCLEIC ACID; MODERN MEDICINE; NANOCARRIERS; NUCLEOLIN; ORAL ROUTE; PHYSICAL CONDITIONS; TARGETED NANOPARTICLE;

ANIMALS; CELL DEATH; CHEMOTHERAPY; DISEASES; DRUG DOSAGE; NUCLEOTIDES; PATIENT TREATMENT; RNA;

NANOPARTICLES;

EID: 84857006930 PISSN: 00049425 EISSN: None Source Type: Journal
DOI: 10.1071/CH11372 Document Type: Review

Times cited : (18)

References (51)

1
- 0027402592
- doi:10.1002/1097-0142(19930215)71:4 ,1368::AID-CNCR2820710432.3.0.CO;2-L
- S. Aznavoorian, A. N. Murphy, W. G. Stetler-Stevenson, L. A. Liotta, Cancer 1993, 71, 1368. doi:10.1002/1097-0142(19930215)71:4 ,1368::AID- CNCR2820710432.3.0.CO;2-L
- (1993) Cancer , vol.71 , pp. 1368
- Aznavoorian, S.¹ Murphy, A.N.² Stetler-Stevenson, W.G.³ Liotta, L.A.⁴

2
- 80054758422
- doi:10.1021/AR2000138
- H. Koo, M. S. Huh, I. C. Sun, S. H. Yuk, K. Choi, K. Kim, Acc. Chem. Res. 2011, 44, 1018. doi:10.1021/AR2000138
- (2011) Acc. Chem. Res. , vol.44 , pp. 1018
- Koo, H.¹ Huh, M.S.² Sun, I.C.³ Yuk, S.H.⁴ Choi, K.⁵ Kim, K.⁶

3
- 84856979417
- M. K. Ma, W. C. Zamboni, K. M. Radomski, W. L. Furman, V. M. Santana, P. J. Houghton, Clin. Cancer Res. 2000, 6, 3.
- (2000) Clin. Cancer Res. , vol.6 , pp. 3
- Ma, M.K.¹ Zamboni, W.C.² Radomski, K.M.³ Furman, W.L.⁴ Santana, V.M.⁵ Houghton, P.J.⁶

4
- 84855417564
- doi:10.1007/S10544-011-9571-1
- J. Calvo, J. L. Lavandera, M. Agueros, J. M. Irache, Biomed. Microdevices 2011, 13, 1015. doi:10.1007/S10544-011-9571-1
- (2011) Biomed. Microdevices , vol.13 , pp. 1015
- Calvo, J.¹ Lavandera, J.L.² Agueros, M.³ Irache, J.M.⁴

5
- 84857018103
- doi:0F80EBAC03395679, 2DF4FCBF590F75DA
- S. A. Galindo-Rodriguez, E. Allemann, H. Fessi, E. Doelker, Crit. Rev. Ther. Drug Carrier Syst. 2005, 22, 5. doi:0F80EBAC03395679, 2DF4FCBF590F75DA
- (2005) Crit. Rev. Ther. Drug Carrier Syst. , vol.22 , pp. 5
- Galindo-Rodriguez, S.A.¹ Allemann, E.² Fessi, H.³ Doelker, E.⁴

6
- 34249782272
- Oral administration of peptides and proteins: Nanoparticles and cyclodextrins as biocompatible delivery systems
- DOI 10.2217/17435889.2.2.183
- A. F. Soares, A. Carvalho Rde, F. Veiga, Nanomedicine 2007, 2, 183. doi:10.2217/17435889.2.2.183 (Pubitemid 46845766)
- (2007) Nanomedicine , vol.2 , Issue.2 , pp. 183-202
- Soares, A.F.¹ De Carvalho, R.A.² Veiga, F.³

7
- 84857002890
- [Epub ahead of print]. doi:10.1007/ S10637-011-9743-0
- Y. Yamada, T. Yamaguchi, H. Matsumoto, Y. Ichikawa, A. Goto, K. Kato, Invest. New Drugs 2011, [Epub ahead of print]. doi:10.1007/ S10637-011-9743-0
- (2011) Invest. New Drugs
- Yamada, Y.¹ Yamaguchi, T.² Matsumoto, H.³ Ichikawa, Y.⁴ Goto, A.⁵ Kato, K.⁶

8
- 77957377256
- doi:10.3797/ SCIPHARM.0911-11
- B. Layek, B. Mukherjee, Sci. Pharm. 2010, 78, 507. doi:10.3797/ SCIPHARM.0911-11
- (2010) Sci. Pharm. , vol.78 , pp. 507
- Layek, B.¹ Mukherjee, B.²

9
- 84855266008
- doi:10.3892/OR.2011.1460
- J. Y. Lee, J. Y. Shin, H. S. Kim, J. I. Heo, Y. J. Kho, H. J. Kang, Oncol. Rep. 2011, 27, 87. doi:10.3892/OR.2011.1460
- (2011) Oncol. Rep. , vol.27 , pp. 87
- Lee, J.Y.¹ Shin, J.Y.² Kim, H.S.³ Heo, J.I.⁴ Kho, Y.J.⁵ Kang, H.J.⁶

10
- 84856984022
- doi:BSP/CMC/E-PUB/2011/146[PII]
- J. R. Kanwar, B. M. Long, R. K. Kanwar, Curr. Med. Chem. 2011, 18, 14. doi:BSP/CMC/E-PUB/2011/146[PII]
- (2011) Curr. Med. Chem. , vol.18 , pp. 14
- Kanwar, J.R.¹ Long, B.M.² Kanwar, R.K.³

11
- 79960016661
- doi:10.2217/NNM.11.48
- J. R. Kanwar, N. Singh, R. K. Kanwar, Nanomedicine 2011, 6, 701. doi:10.2217/NNM.11.48
- (2011) Nanomedicine , vol.6 , pp. 701
- Kanwar, J.R.¹ Singh, N.² Kanwar, R.K.³

12
- 84857021181
- J. R. Kanwar, G. Mahidhara, R. K. Kanwar, Curr. Nanosci. 2009, 5, 4.
- (2009) Curr. Nanosci. , vol.5 , pp. 4
- Kanwar, J.R.¹ Mahidhara, G.² Kanwar, R.K.³

13
- 79952440644
- doi:10.1016/J.DRUDIS.2011.01.007
- J. R. Kanwar, G. Mahidhara, R. K. Kanwar, Drug Discov. Today 2011, 16, 5. doi:10.1016/J.DRUDIS.2011.01.007
- (2011) Drug Discov. Today , vol.16 , pp. 5
- Kanwar, J.R.¹ Mahidhara, G.² Kanwar, R.K.³

14
- 81855218276
- doi:10.3109/10409238.2011.614592
- J. R. Kanwar, K. R. Roy, R. K. Kanwar, Crit. Rev. Biochem. Mol. Biol. 2011, 46, 6. doi:10.3109/10409238.2011.614592
- (2011) Crit. Rev. Biochem. Mol. Biol. , vol.46 , pp. 6
- Kanwar, J.R.¹ Roy, K.R.² Kanwar, R.K.³

15
- 78650073758
- doi:10.2217/NNM.10.115
- J. R. Kanwar, R. R. Mohan, R. K. Kanwar, K. Roy, R. Bawa, Nanomedicine 2010, 5, 1435. doi:10.2217/NNM.10.115
- (2010) Nanomedicine , vol.5 , pp. 1435
- Kanwar, J.R.¹ Mohan, R.R.² Kanwar, R.K.³ Roy, K.⁴ Bawa, R.⁵

16
- 77956644503
- J. R. Kanwar, G. Mahidhara, R. K. Kanwar, Front Biosci. (Schol. Ed). 2010, 2, 1113.
- (2010) Front Biosci. (Schol. Ed). , vol.2 , pp. 1113
- Kanwar, J.R.¹ Mahidhara, G.² Kanwar, R.K.³

17
- 0037601888
- Requirements for ICAM-1 immunogene therapy of lymphoma
- DOI 10.1038/sj.cgt.7700590
- J. R. Kanwar, R. W. Berg, Y. Yang, R. K. Kanwar, L. M. Ching, X. Sun, G. W. Krissansen, Cancer Gene Ther. 2003, 10, 468. doi:10.1038/SJ.CGT.7700590 (Pubitemid 36667133)
- (2003) Cancer Gene Therapy , vol.10 , Issue.6 , pp. 468-476
- Kanwar, J.R.¹ Berg, R.W.² Yang, Y.³ Kanwar, R.K.⁴ Ching, L.M.⁵ Sun, X.⁶ Krissansen, G.W.⁷

18
- 0141851079
- Mouse B7-H3 induces antitumor immunity
- DOI 10.1038/sj.gt.3302070
- X. Sun, M. Vale, E. Leung, J. R. Kanwar, R. Gupta, G. W. Krissansen, Gene Ther. 2003, 10, 20. doi:10.1038/SJ.GT.3302070 (Pubitemid 37121044)
- (2003) Gene Therapy , vol.10 , Issue.20 , pp. 1728-1734
- Sun, X.¹ Vale, M.² Leung, E.³ Kanwar, J.R.⁴ Gupta, R.⁵ Krissansen, G.W.⁶

19
- 84856984883
- J. R. Kanwar, R. K. Kanwar, S. Pandey, L. M. Ching, G. W. Krissansen, Cancer Res. 2001, 61, 5.
- (2001) Cancer Res. , vol.61 , pp. 5
- Kanwar, J.R.¹ Kanwar, R.K.² Pandey, S.³ Ching, L.M.⁴ Krissansen, G.W.⁵

20
- 0035904376
- doi:10.1093/JNCI/93.20.1541
- J. R. Kanwar,W. P. Shen, R. K. Kanwar, R. W. Berg, G. W.Krissansen, J. Natl. Cancer Inst. 2001, 93, 1541. doi:10.1093/JNCI/93.20.1541
- (2001) J. Natl. Cancer Inst. , vol.93 , pp. 1541
- Kanwar, J.R.¹ Shen, W.P.² Kanwar, R.K.³ Berg, R.W.⁴ Krissansen, G.W.⁵

21
- 0032736478
- Taking lessons from dendritic cells: Multiple xenogeneic ligands for leukocyte integrins have the potential to stimulate anti-tumor immunity
- DOI 10.1038/sj.gt.3301016
- J. Kanwar, R. Berg, K. Lehnert, G. Krissansen, Gene Ther. 1999, 6, 1835. doi:10.1038/SJ.GT.3301016 (Pubitemid 29531279)
- (1999) Gene Therapy , vol.6 , Issue.11 , pp. 1835-1844
- Kanwar, J.R.¹ Berg, R.W.² Lehnert, K.³ Krissansen, G.W.⁴

22
- 65949088798
- doi:10.2174/157341309787314665
- S. Baratchi, R. K. Kanwar, K. Khoshmanesh, P. Vasu, C. Ashok, M. Hittu,Curr. Nanosci. 2009, 5, 15. doi:10.2174/157341309787314665
- (2009) Curr. Nanosci. , vol.5 , pp. 15
- Baratchi, S.¹ Kanwar, R.K.² Khoshmanesh, K.³ Vasu, P.⁴ Ashok, C.⁵ Hittu, M.⁶

23
- 1542291181
- Nanoparticles of biodegradable polymers for clinical administration of paclitaxel
- DOI 10.2174/0929867043455909
- S. S. Feng, L. Mu, K. Y. Win, G. Huang, Curr. Med. Chem. 2004, 11, 413. doi:10.2174/0929867043455909 (Pubitemid 38294346)
- (2004) Current Medicinal Chemistry , vol.11 , Issue.4 , pp. 413-424
- Feng, S.-S.¹ Mu, L.² Win, K.Y.³ Huang, G.⁴

24
- 57749108568
- doi:10.1158/1535-7163.MCT-08-0476
- S. Bisht, G. Feldmann, J. B. Koorstra, M. Mullendore, H. Alvarez, C. Karikari, M. A. Rudek, C. K. Lee, A. Maitra, A. Maitra, Mol. Cancer Ther. 2008, 7, 3878. doi:10.1158/1535-7163.MCT-08-0476
- (2008) Mol. Cancer Ther. , vol.7 , pp. 3878
- Bisht, S.¹ Feldmann, G.² Koorstra, J.B.³ Mullendore, M.⁴ Alvarez, H.⁵ Karikari, C.⁶ Rudek, M.A.⁷ Lee, C.K.⁸ Maitra, A.⁹ Maitra, A.¹⁰

25
- 84857027951
- A. Mukerjee, J. K. Vishwanatha, Anticancer Res. 2009, 29, 10.
- (2009) Anticancer Res. , vol.29 , pp. 10
- Mukerjee, A.¹ Vishwanatha, J.K.²

26
- 84255167372
- H. Chen, Y. Zheng, G. Tian, Y. Tian, X. Zeng, G. Liu, Nanoscale Res. Lett. 2011, 6, 1.
- (2011) Nanoscale Res. Lett. , vol.6 , pp. 1
- Chen, H.¹ Zheng, Y.² Tian, G.³ Tian, Y.⁴ Zeng, X.⁵ Liu, G.⁶

27
- 70350244685
- doi:10.1007/S11095-009-9965-4
- V. Bhardwaj, D.D. Ankola, S.C. Gupta, M. Schneider, C. M. Lehr, M.N. Kumar, Pharm. Res. 2009, 26, 2495. doi:10.1007/S11095-009-9965-4
- (2009) Pharm. Res. , vol.26 , pp. 2495
- Bhardwaj, V.¹ Ankola, D.D.² Gupta, S.C.³ Schneider, M.⁴ Lehr, C.M.⁵ Kumar, M.N.⁶

28
- 34247645112
- Development of biodegradable nanoparticles for oral delivery of ellagic acid and evaluation of their antioxidant efficacy against cyclosporine A-induced nephrotoxicity in rats
- DOI 10.1007/s11095-006-9207-y
- K. Sonaje, J. L. Italia, G. Sharma, V. Bhardwaj, K. Tikoo, M. N. Kumar, Pharm. Res. 2007, 24, 899. doi:10.1007/S11095-006-9207-Y (Pubitemid 46675391)
- (2007) Pharmaceutical Research , vol.24 , Issue.5 , pp. 899-908
- Sonaje, K.¹ Italia, J.L.² Sharma, G.³ Bhardwaj, V.⁴ Tikoo, K.⁵ Kumar, M.N.V.R.⁶

29
- 84856994900
- N. Klauber, S. Parangi, E. Flynn, E. Hamel, R. J. D'Amato, Cancer Res. 1997, 57, 1.
- (1997) Cancer Res. , vol.57 , pp. 1
- Klauber, N.¹ Parangi, S.² Flynn, E.³ Hamel, E.⁴ D'Amato, R.J.⁵

30
- 46949110744
- An orally delivered small-molecule formulation with antiangiogenic and anticancer activity
- DOI 10.1038/nbt1415, PII NBT1415
- O. Benny, O. Fainaru, A. Adini, F. Cassiola, L. Bazinet, I. Adini, E. Pravda, Y. Nahmias, S. Koirala, G. Korfas, R. J. D'Amato, J. Folkman, Nat. Biotechnol. 2008, 26, 799. doi:10.1038/NBT1415 (Pubitemid 351961454)
- (2008) Nature Biotechnology , vol.26 , Issue.7 , pp. 799-807
- Benny, O.¹ Fainaru, O.² Adini, A.³ Cassiola, F.⁴ Bazinet, L.⁵ Adini, I.⁶ Pravda, E.⁷ Nahmias, Y.⁸ Koirala, S.⁹ Corfas, G.¹⁰ D'Amato, R.J.¹¹ Folkman, J.¹²

31
- 84857020161
- P. F. Jiao, H.Y. Zhou, L.X. Chen, B. Yan, Curr Med Chem. 2011, 18, 14.
- (2011) Curr Med Chem. , vol.18 , pp. 14
- Jiao, P.F.¹ Zhou, H.Y.² Chen, L.X.³ Yan, B.⁴

32
- 79957967637
- doi:10.1016/J.JSPS.2011.04.001
- S. R. Mudshinge, A. B. Deore, S. Patil, C. M. Bhalgat, Saudi Pharm. J. 2011, 19, 129. doi:10.1016/J.JSPS.2011.04.001
- (2011) Saudi Pharm. J. , vol.19 , pp. 129
- Mudshinge, S.R.¹ Deore, A.B.² Patil, S.³ Bhalgat, C.M.⁴

33
- 84857025118
- J. U. Junghanns, R. H. Muller, Int. J. Nanomed. 2008, 3, 3.
- (2008) Int. J. Nanomed. , vol.3 , pp. 3
- Junghanns, J.U.¹ Muller, R.H.²

34
- 34548630860
- doi:10.2147/ NANO.2006.1.2.117
- K. Bowman, K. W. Leong, Int. J. Nanomed. 2006, 1, 117. doi:10.2147/ NANO.2006.1.2.117
- (2006) Int. J. Nanomed. , vol.1 , pp. 117
- Bowman, K.¹ Leong, K.W.²

35
- 83555165984
- [Epub ahead of print]. doi:10.1002/JAT.1718
- M. Mahmood, D. Casciano, Y. Xu, A. S. Biris, J. Appl. Toxicol. 2011, [Epub ahead of print]. doi:10.1002/JAT.1718
- (2011) J. Appl. Toxicol.
- Mahmood, M.¹ Casciano, D.² Xu, Y.³ Biris, A.S.⁴

36
- 79952010666
- S. Kamboj, S. Bala, A. B. Nair, Int. J. Pharm. Sci. Rev. Res. 2010, 5, 2.
- (2010) Int. J. Pharm. Sci. Rev. Res. , vol.5 , pp. 2
- Kamboj, S.¹ Bala, S.² Nair, A.B.³

37
- 79956215352
- doi:10.1517/17425247.2011.572069
- M. Agüeros, S. Espuelas, I. Esparza, P. Calleja, I. Penuelas, G. Ponchel, J. M. Irache, Expert Opin. Drug Deliv. 2011, 8, 721. doi:10.1517/17425247.2011.572069
- (2011) Expert Opin. Drug Deliv. , vol.8 , pp. 721
- Agüeros, M.¹ Espuelas, S.² Esparza, I.³ Calleja, P.⁴ Penuelas, I.⁵ Ponchel, G.⁶ Irache, J.M.⁷

38
- 60049101453
- doi:10.1007/S11095-008-9773-2
- C. S. Brazel, Pharm. Res. 2009, 26, 644. doi:10.1007/S11095-008-9773-2
- (2009) Pharm. Res. , vol.26 , pp. 644
- Brazel, C.S.¹

39
- 77955417363
- doi:10.1016/J.JCONREL.2010.04.004
- K. Kim, J. H. Kim, H. Park, Y. S. Kim, K. Park, H. Nam, S. Lee, J. H. Park, R.-W. Park, I.-S. Kim, K. Choi, S. Y. Kim, K. Park, J. Controlled Release 2010, 146, 219. doi:10.1016/J.JCONREL.2010.04.004
- (2010) J. Controlled Release , vol.146 , pp. 219
- Kim, K.¹ Kim, J.H.² Park, H.³ Kim, Y.S.⁴ Park, K.⁵ Nam, H.⁶ Lee, S.⁷ Park, J.H.⁸ Park, R.-W.⁹ Kim, I.-S.¹⁰ Choi, K.¹¹ Kim, S.Y.¹² Park, K.¹³

40
- 84857025299
- J. B. Share, Am. J. Ment. Defic. 1976, 80, 4.
- (1976) Am. J. Ment. Defic. , vol.80 , pp. 4
- Share, J.B.¹

41
- 70349431228
- doi:10.1016/J.COPH.2009.07.006
- E. Dausse, S. Da Rocha Gomes, J. J. Toulme, Curr. Opin. Pharmacol. 2009, 9, 602. doi:10.1016/J.COPH.2009.07.006
- (2009) Curr. Opin. Pharmacol. , vol.9 , pp. 602
- Dausse, E.¹ Da Rocha Gomes, S.² Toulme, J.J.³

42
- 84856981009
- press
- J. R. Kanwar, R. K. Kanwar, Protein Pept. Lett. 2012, in press.
- (2012) Protein Pept. Lett.
- Kanwar, J.R.¹ Kanwar, R.K.²

43
- 41149130729
- 'Iron-saturated' lactoferrin is a potent natural adjuvant for augmenting cancer chemotherapy
- DOI 10.1038/sj.icb.7100163, PII 7100163
- J. R. Kanwar, K. P. Palmano, X. Sun, R. K. Kanwar, R. Gupta, N. Haggarty, A. Rowan, S. Ram, G. W. Krissansen, Immunol. Cell. Biol. 2008, 86, 277. doi:10.1038/SJ.ICB.7100163 (Pubitemid 351430811)
- (2008) Immunology and Cell Biology , vol.86 , Issue.3 , pp. 277-288
- Kanwar, J.R.¹ Palmano, K.P.² Sun, X.³ Kanwar, R.K.⁴ Gupta, R.⁵ Haggarty, N.⁶ Rowan, A.⁷ Ram, S.⁸ Krissansen, G.W.⁹

44
- 0036567147
- doi:10.1093/NAR/30.9.1911
- J. Kurreck, E. Wyszko, C. Gillen, V. A. Erdmann, Nucleic Acids Res. 2002, 30, 1911. doi:10.1093/NAR/30.9.1911
- (2002) Nucleic Acids Res. , vol.30 , pp. 1911
- Kurreck, J.¹ Wyszko, E.² Gillen, C.³ Erdmann, V.A.⁴

45
- 33645808435
- doi:10.1007/3-540-27262-3-21
- S. Kauppinen, B. Vester, J. Wengel, Handbook of Experimental Pharmacology 2006, 173, 405. doi:10.1007/3-540-27262-3-21
- (2006) Handbook of Experimental Pharmacology , vol.173 , pp. 405
- Kauppinen, S.¹ Vester, B.² Wengel, J.³

46
- 84857020011
- [Epub ahead of print]. doi:10.1038/LEU.2011.199LEU2011199[PII]
- D. J. Morrison, L. E. Hogan, G. Condos, T. Bhatla, N. Germino, N. P. Moskowitz, L. Lee, D. Bhojwani, T. M. Horton, I. Belitskaya-Levy, L.M.Greenberger, I.D.Horak, S.A.Grupp,D. T. Teachey, E.A. Raetz, W. L. Carroll, Leukemia 2011, [Epub ahead of print]. doi:10.1038/LEU.2011.199LEU2011199[PII]
- (2011) Leukemia
- Morrison, D.J.¹ Hogan, L.E.² Condos, G.³ Bhatla, T.⁴ Germino, N.⁵ Moskowitz, N.P.⁶ Lee, L.⁷ Bhojwani, D.⁸ Horton, T.M.⁹ Belitskaya-Levy, I.¹⁰ Greenberger, L.M.¹¹ Horak, I.D.¹² Grupp, S.A.¹³ Teachey, D.T.¹⁴ Raetz, E.A.¹⁵ Carroll, W.L.¹⁶

47
- 80052148548
- doi:10.1182/BLOOD-2010-08-299354
- E. Park, E. J. Gang, Y. T. Hsieh, P. Schaefer, S. Chae, L. Klemm, S. Huantes, M. Loh, E. M. Conway, E. S. Kang, H. Hoe Koo, W. K. Hofmann, N. Heisterkamp, L. Pelus, G. Keerthivasan, J. Crispino, M. Kahn, M. Müschen, Y. M. Kim, Blood 2011, 118, 2191. doi:10.1182/BLOOD-2010-08-299354
- (2011) Blood , vol.118 , pp. 2191
- Park, E.¹ Gang, E.J.² Hsieh, Y.T.³ Schaefer, P.⁴ Chae, S.⁵ Klemm, L.⁶ Huantes, S.⁷ Loh, M.⁸ Conway, E.M.⁹ Kang, E.S.¹⁰ Hoe Koo, H.¹¹ Hofmann, W.K.¹² Heisterkamp, N.¹³ Pelus, L.¹⁴ Keerthivasan, G.¹⁵ Crispino, J.¹⁶ Kahn, M.¹⁷ Müschen, M.¹⁸ Kim, Y.M.¹⁹

48
- 42049124068
- The nucleolin targeting aptamer AS1411 destabilizes Bcl-2 messenger RNA in human breast cancer cells
- DOI 10.1158/0008-5472.CAN-07-5723
- S. Soundararajan, W. Chen, E. K. Spicer, N. Courtenay-Luck, D. J. Fernandes, Cancer Res. 2008, 68, 2358. doi:10.1158/0008-5472.CAN-07-5723 (Pubitemid 351521810)
- (2008) Cancer Research , vol.68 , Issue.7 , pp. 2358-2365
- Soundararajan, S.¹ Chen, W.² Spicer, E.K.³ Courtenay-Luck, N.⁴ Fernandes, D.J.⁵

49
- 79954858874
- doi:10.1111/J.1349-7006.2011.01897.X
- S. Shigdar, J. Lin, Y. Yu, M. Pastuovic, M. Wei, W. Duan, Cancer Sci. 2011, 102, 991. doi:10.1111/J.1349-7006.2011.01897.X
- (2011) Cancer Sci. , vol.102 , pp. 991
- Shigdar, S.¹ Lin, J.² Yu, Y.³ Pastuovic, M.⁴ Wei, M.⁵ Duan, W.⁶

50
- 0344874534
- Use of locked nucleic acid oligonucleotides to add functionality to plasmid DNA
- DOI 10.1093/nar/gkg801
- K. M. Hertoghs, J. H. Ellis, I. R. Catchpole, Nucleic Acids Res. 2003, 31, 5817. doi:10.1093/NAR/GKG801 (Pubitemid 37442308)
- (2003) Nucleic Acids Research , vol.31 , Issue.20 , pp. 5817-5830
- Hertoghs, K.M.L.¹ Ellis, J.H.² Catchpole, I.R.³

51
- 84856984026
- press
- G. Mahidhara, R. K. Kanwar, J. R. Kanwar, Int. J. Nanotechnol. 2012, in press.
- (2012) Int. J. Nanotechnol.
- Mahidhara, G.¹ Kanwar, R.K.² Kanwar, J.R.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.